NewsNational

Actions

Lot of Xanax tablets recalled nationwide due to possible 'presence of foreign substance'

Posted: 1:44 PM, Oct 28, 2019
Updated: 2019-10-28 14:27:55-04
Lot of Xanax tablets recalled nationwide due to possible 'presence of foreign substance'

Mylan Pharmaceuticals Inc. is voluntarily recalling one lot of Alprazolam Tablets, more commonly known by its brand name Xanax, "due to the potential presence of foreign substance."

According to the recall on the U.S. Food and Drug Administration website, the clinical impact from the foreign substance is expected to be rare, "but the remote risk of infection to a patient cannot be ruled out."

The recall, issued October 25, affects one lot of the prescription anti-anxiety drug that was distributed between July and August 2019.

Specifics on the recalled product are listed below.

NDC
Product Description and Strength
Size
Lot number
Expiry
0378-4003-05Alprazolam Tablets, USP C-IV 0.5 mgBottles of 5008082708September 2020

The "potential foreign substance" hasn't been identified by the pharmaceutical company.

Consumers with questions regarding this recall can contact Mylan Customer Relations at 1-800-796-9526 or customer.service@mylan.com, 8 a.m.-5 p.m. EST Monday-Friday.